Keywords: Tumors (Pre-Treatment), Brain, glioma; glioblastoma; molecular glioblastoma
Motivation: Whether molecular GBMs are equivalent to early histological GBMs are controversial.
Goal(s): To compare the clinicopathologic, imaging, surgical factors, and prognosis between molecular GBMs and histological GBMs.
Approach: Retrospective chart and imaging review was performed in 974 IDH-wildtype GBM patients (43 molecular GBMs and 931 histological GBMs) from a single institution.
Results: Molecular GBMs were significantly younger with higher rate of TERTp, higher incidence of gliomatosis cerebri and non-lobar location compared with histological GBMs, resulting in less aggressive resection. Survival was significantly longer in molecular GBM, which was attributed to the longer OS in histological grade 2 molecular GBMs with isolated TERTp mutation.
Impact: Discordant clinicopathologic, imaging, and surgical features suggest molecular GBMs may not be equivalent to early histological GBMs. Histological grade 2 molecular GBMs with isolated TERTp mutation may not be sufficient to assume an aggressive clinical behavior similar to histological GBM.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords